Don’t let winter ailments slow you down. Discover how understanding your symptoms can lead to powerful relief while embracing ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively against the industry than during his first term— pulling vaccine ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

By Hugo Francisco de Souza New research reveals that vaccines enhanced with the AS01 adjuvant may help shield the aging brain ...

Norwegian offshore services provider DOF Group has secured two new contracts in Brazil. The Skandi Logger, an anchor handling ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer and Moderna COVID-19 vaccines.The FDA is expanding warnings on Pfizer and ...

The machine was placed outside of the Polk County Health Department in early May. It provides 24/7 access to free items like ...

The committee chair hinted at banning MMR shots for certain children, said Naomi Rogers, a science historian at Yale University.

Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.